Clinical Trial Detail

NCT ID NCT03787498
Title A Study of PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Plexxikon
Indications

acute myeloid leukemia

myelodysplastic syndrome

Therapies

PLX2853

Age Groups: adult senior

No variant requirements are available.